Specifications
| SKU | ISG007107 |
| Brand | تيكافير |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 0.5 Mg |
| Shop by Concerns | Chronic Hepatitis |
| Gender | Neutral |
| Shop By Goals | Bacterial Control |
| Imported Or Local | Local |
| Ingredient | Entecavir |
| UPC | 6223002459810 |
| Specialty | Antiviral Clinically Tested Prescription only |
| Sub Categories | Anti Viral |
| Warning | Dose adjustment in renal impairment Monitor liver and kidney function regularly Not for self-medication in pregnancy Use under medical supervision Risk of hepatitis flare on discontinuation |
About the product›
Tecavir 0.5 Mg
Description:
Tecavir 0.5 mg is a prescription antiviral medicine containing entecavir, a nucleoside analogue reverse transcriptase inhibitor used for the long-term treatment of chronic hepatitis B virus (HBV) infection. It works by inhibiting HBV polymerase, thereby reducing viral replication, lowering viral load, and helping to limit liver damage. Tecavir 0.5 mg film-coated tablets are intended for adult patients and selected adolescents as directed by a hepatologist or infectious disease specialist.
Indications:
- Treatment of chronic hepatitis B virus (HBV) infection in adults with evidence of active viral replication.
- Indicated in patients with persistent elevations in serum aminotransferases (ALT or AST) and/or histologically active liver disease.
- Helps reduce HBV DNA levels and improve liver function tests.
- May help slow progression of liver disease and reduce the risk of complications such as cirrhosis, hepatic decompensation, and hepatocellular carcinoma when used as part of comprehensive medical care.
Active Ingredients / Key Components:
- Entecavir – 0.5 mg per film-coated tablet.
- Other inactive ingredients (excipients) are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); full excipient list is provided in the official package insert.
Dosage & Administration / How to Use:
- Standard adult dose for nucleoside-naïve patients with chronic hepatitis B: 0.5 mg entecavir once daily, or as prescribed by the treating physician.
- Take orally with a glass of water. It may be taken on an empty stomach; follow your doctor’s specific instructions regarding food intake.
- For patients with prior lamivudine resistance, decompensated liver disease, or renal impairment, dosage adjustments and different strengths may be required; dosing must be individualized by a specialist.
- Take the tablet at the same time each day to maintain consistent blood levels.
- Do not stop Tecavir 0.5 mg without consulting your doctor, as abrupt discontinuation may lead to severe acute exacerbation of hepatitis B.
- If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
- Use only under medical supervision, with regular monitoring of liver function tests, HBV DNA levels, and kidney function as recommended by your physician.
Clinical Benefits:
- Effectively suppresses hepatitis B virus replication by inhibiting HBV polymerase activity.
- Helps reduce HBV DNA levels and improve liver enzyme levels (ALT, AST), supporting better liver function.
- May slow the progression of chronic hepatitis B to advanced liver disease, including cirrhosis and liver failure, when used as part of comprehensive care.
- Contributes to lowering the risk of long-term complications such as hepatic decompensation and hepatocellular carcinoma in appropriately selected patients.
Warnings & Contraindications:
- Use only under the supervision of a qualified healthcare professional experienced in the management of chronic hepatitis B.
- Contraindicated in patients with known hypersensitivity to entecavir or any component of the formulation.
- Severe acute exacerbations of hepatitis B have been reported in patients who discontinued anti-hepatitis B therapy, including entecavir; patients should be closely monitored clinically and with laboratory tests for at least several months after stopping treatment.
- Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with nucleoside analogues; use with caution in patients with risk factors for liver disease or lactic acidosis.
- Renal impairment: Dose adjustment may be required in patients with reduced kidney function; monitor renal parameters regularly.
- HIV co-infection: Entecavir is not recommended as monotherapy in patients with HIV/HBV co-infection who are not receiving a fully suppressive antiretroviral regimen, as it may lead to HIV resistance.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. The physician will weigh potential benefits and risks.
- Use with caution in patients with advanced liver disease, history of liver transplantation, or other serious medical conditions; close monitoring is required.
- Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
- Keep out of reach of children.
Side Effects:
- Common side effects may include headache, fatigue, dizziness, nausea, diarrhea, indigestion, and sleep disturbances.
- Less common side effects can include increased liver enzymes, rash, and elevated blood creatinine or other laboratory abnormalities.
- Serious but rare side effects may include lactic acidosis, severe hepatomegaly with steatosis, severe liver function deterioration, and hypersensitivity reactions.
- Seek immediate medical attention if you experience symptoms such as unusual muscle pain, rapid breathing, persistent nausea and vomiting, severe weakness, abdominal pain, jaundice (yellowing of skin or eyes), dark urine, or swelling of the face, lips, or tongue.
- Report any unexpected or persistent side effects to your healthcare provider promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.
Specifications:
- Active ingredient: entecavir 0.5 mg per film-coated tablet.
- Product form: film-coated tablets for oral use.
- Pack size: 30 film-coated tablets (30 f.c. tab.) per pack.
- Intended use: prescription antiviral medicine for chronic hepatitis B in adults and as directed by a specialist.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
